Barcelona - Spain (3 days working from the office and 2 days working from home)
Were resetting expectations of what a bio-pharmaceutical company can be. The BioPharmaceuticals unit (BBU) of AstraZeneca focuses on development and commercialization of AstraZeneca's Respiratory, Immunology, Cardiovascular, Metabolic, Renal, and Infectious Disease therapeutic areas. Global Insights and Business Excellence (GIBEx) is a strategic function critical for enabling success in the growth of the BBU business. Our ambition is to build an industry-leading organization, empowering our Commercial teams through the generation of compelling evidence and insights, while ensuring they have the tools and skills to deliver impactful launches that change the practice of medicine for the benefit of patients. Within GIBEx, the Insights, Analytics, and Forecasting (IA&F;) function supports both the US and Global organizations and is structured by therapy area:



Team Overview The Global CVRM IA&F; Early Assets and Business Development team serves as a strategic business partner to the CVRM Early Commercial & Strategy group and the R&D; Integral Product Teams, providing market insights that drive key commercial investment decisions and therapeutic area strategy development.
Job Description The CVRM IA&F; Early Assets and Business Development Lead is expected to provide leadership and strategic direction to deliver competitive advantages through the application of end-to-end insights, analytics, and forecasts across the Global markets to support AstraZeneca's industry-leading CVRM pipeline. Our mission as a team is to improve the quality of the company's investment decisions to support corporate growth targets. To achieve this, the CVRM Early Assets IA&F; team is tasked with delivering excellence in market research, customer and competitor insights, data analytics, and forecasting.
In addition to strong analytical and forecasting skills, the CVRM Early Assets and Business Development Lead should have ex

📌 Global Insights, Analytics, and Forecasting Lead, CVRM Early Assets and Business Development (Barcelona)
🏢 Astrazeneca
📍 Barcelona